Vertex Pharmaceuticals (VRTX) Non-Current Deferred Tax Liability (2009 - 2018)
Vertex Pharmaceuticals (VRTX) posted Non-Current Deferred Tax Liability of $9.4 million for Q3 2018, up 0.85% on a QoQ basis from $9.3 million in Q2 2018, and down 11.87% year-over-year from $10.7 million in Q3 2017.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Non-Current Deferred Tax Liability (2009 - 2018) Analysis & Trends
Vertex Pharmaceuticals has reported Non-Current Deferred Tax Liability for 10 years, with the latest figure at $9.4 million in Q3 2018.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 11.87% year-over-year to $9.4 million in Q3 2018; TTM through Sep 2018 was $9.4 million, a 11.87% decrease from a year earlier, with the FY2017 full-year figure at $6.3 million, down 95.27% from the prior year.
- Non-Current Deferred Tax Liability was $9.4 million for Q3 2018 at Vertex Pharmaceuticals, up from $9.3 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $136.6 million in Q2 2017, with the low at $6.3 million in Q4 2017.
- Average Non-Current Deferred Tax Liability over 5 years is $74.8 million, with a median of $111.3 million recorded in 2015.
- The sharpest annual moves came in 2016 and 2017: Non-Current Deferred Tax Liability surged 643.78% in 2016, then plunged 95.27% in 2017.
- Over 5 years, Non-Current Deferred Tax Liability stood at $15.0 million in 2014, then surged by 634.11% to $110.4 million in 2015, then gained by 21.39% to $134.1 million in 2016, then plunged by 95.27% to $6.3 million in 2017, then surged by 48.46% to $9.4 million in 2018.
- The last three Non-Current Deferred Tax Liability figures came in at $9.4 million (Q3 2018), $9.3 million (Q2 2018), and $9.6 million (Q1 2018), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 9.41 Mn |
| Jun 30, 2018 | 9.34 Mn |
| Mar 31, 2018 | 9.64 Mn |
| Dec 31, 2017 | 6.34 Mn |
| Sep 30, 2017 | 10.68 Mn |
| Jun 30, 2017 | 136.65 Mn |
| Mar 31, 2017 | 135.40 Mn |
| Dec 31, 2016 | 134.06 Mn |
| Sep 30, 2016 | 133.27 Mn |
| Jun 30, 2016 | 132.81 Mn |
| Mar 31, 2016 | 112.26 Mn |
| Dec 31, 2015 | 110.44 Mn |
| Sep 30, 2015 | 113.86 Mn |
| Jun 30, 2015 | 112.41 Mn |
| Mar 31, 2015 | 15.09 Mn |
| Dec 31, 2014 | 15.04 Mn |
| Sep 30, 2013 | 150.20 Mn |
| Jun 30, 2013 | 149.71 Mn |
| Mar 31, 2013 | 151.66 Mn |
| Dec 31, 2012 | 280.37 Mn |
API Access
Vertex Pharmaceuticals Non-Current Deferred Tax Liability API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deferred-tax-liability", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();